References

1. King H, Aubert RE, Herman WH. Global burden of diabetes, 1995 -2025. Prevalence, numerical estimates, and projections. Diabetes Care 1998; 21:1414-1431.

2. Mokdad AH, Ford ES, Bowman BA, Nelson DE, Engelgau MM, Vinicor F, Marks JS. Diabetes trends in the U.S.: 1990-1998. Diabetes Care 2000; 23:12781283.

3. Harris MI, Flegal KM, Cowie CC, Eberhardt MS, Goldstein DE, Little RR, Wiedmeyer HM, Byrd-Holt DD. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988-1994. Diabetes Care 1988; 21:518-524.

4. Carter JS, Pugh JA, Monterrosa A. Non-insulin-dependent diabetes mellitus in minorities in the United States. Ann Intern Med 1996; 125:221-232.

5. The National High Blood Pressure Education Program Working Group. National high blood pressure education program working group report on hypertension in diabetes. Hypertension 1994; 23:145-158.

6. Gu K, Cowie CC, Harris MI. Mortality in adults with and without diabetes in a national cohort of the U.S. population, 1971-1993. Diabetes Care 1998; 21:11381145.

7. Harris MI. Diabetes in America: Epidemiology and scope of the problem. Diabetes Care 1998; 21:C11-C14.

8. Kannel WB, Hjortland M, Castelli WP. Role of diabetes in congestive heart failure: The Framingham Study. Am J Cardiol 1974; 34:29-34.

9. Kannel WB, McGee DL. Diabetes and cardiovascular disease. The Framingham Study. JAMA 1979; 241:2035-2038.

10. Kannel WB, McGee DL. Diabetes and cardiovascular risk factors: The Framingham Study. Circulation 1979; 59:8-13.

11. Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 1998; 339:229-234.

12. Consensus statement. Treatment of hypertension in diabetes. Diabetes Care 1996; 19:S107-S113.

13. The Hypertension in Diabetes Study Group. Hypertension in Diabetes Study (HDS): II. Increased risk of cardiovascular complications in hypertensive type 2 diabetic patients. J Hypertens 1993; 11:319-325. |

14. Rossing P, Hougaard P, Borch-Johnsen K, Parving HH. Predictors of mortality in insulin dependent diabetes: 10-year observational follow up study. Br Med J 1996; S

15. Stamler J, Vaccaro O, Neaton JD, Wentworth D. Diabetes, other risk factors, and "„ 12-yr cardiovascular mortality for men screened in the Multiple Risk Intervention ^ Trial. Diabetes Care 1993; 16:434-444. Q

16. Christensen CK, Mogensen CE. The course of incipient diabetic nephropathy: studies of albumin excretion and blood pressure. Diabetic Med 1985; 2:97-102.

17. Savage S, Schrier RW. Progressive renal insufficiency: the role of angiotensin converting enzyme inhibitors. Adv Intern Med 1992; 37:85-101.

18. Knowler WC, Bennett PH, Ballintine EJ. Increased incidence of retinopathy in diabetes with elevated blood pressure. A six-year follow-up study in Pima Indians. N Engl J Med 1980; 302:645-650.

19. Ishihara M, Yukimura Y, Aizawa T, Yamada T, Ohto K, Yoshizawa K. High blood pressure as risk factor in diabetic retinopathy development in NIDDM patients. Diabetes Care 1987; 10:20-25.

20. Klein R, Klein BE, Moss SE, Davis MD, DeMets DL. Is blood pressure a predictor of the incidence or progression of diabetic retinopathy? Arch Intern Med 1989; 149: 2427-2432.

21. Maser RE, Steenkiste AR, Dorman JS, Nielsen VK, Bass EB, Manjoo Q, Drash AL, Becker DJ, Kuller LH, Greene DA et al. Epidemiological correlates of diabetic neuropathy. Report from Pittsburgh Epidemiology of Diabetes Complications Study. Diabetes 1989; 38:1456-1461.

22. Keller CK, Bergis KH, Fliser D, Ritz E. Renal findings in patients with short-term type 2 diabetes. J Am Soc Nephrol 1996; 7:2627-2635.

23. Barzilay J, Warram JH, Bak M, Laffel LMB, Canessa M, Krolewski AS. Predisposition to hypertension: Risk factor for nephropathy and hypertension in IDDM. Kidney Int 1992; 41:723-730.

24. Krolewski AS, Canessa M, Warram JH, Laffel LM, Christlieb AR, Knowler WC, Rand LI. Predisposition to hypertension and susceptibility to renal disease in insulin-dependent diabetes mellitus. N Engl J Med 1998; 318:140-145.

25. Fujita J, Tsuda K, Seno M, Obayashi H, Fukui I, Seino Y. Erythrocyte sodium-lithium countertransport activity as a marker of predisposition to hypertension and diabetic nephropathy in NIDDM. Diabetes Care 1994; 17:977-982.

26. Trevisan R, Viberti G. Sodium-hydrogen antiporter: its possible role in the genesis of diabetic nephropathy. Nephrol Dial Transplant 1997; 12:643-645.

27. Weidmann P, Beretta-Piccoli C, Trost BN. Pressor factors and responsiveness in hypertension accompanying diabetes mellitus. Hypertension 1985; 7:II33-II42.

28. Roland JM, O'Hare JP, Walters G, Corrall RJ. Sodium retention in response to saline infusion in uncomplicated diabetes mellitus. Diabetes Res 1986; 3:213215.

29. Weidmann P, Ferrari P. Central role of sodium in hypertension in diabetic subjects. Diabetes Care 1991; 14:220-232.

30. Christlieb AR, Kaldany A, D'Elia JA. Plasma renin activity and hypertension in diabetes mellitus. Diabetes 1976; 25:969-974.

31. Price DA, De'Oliveira JM, Fisher ND, Williams GH, Hollenberg NK. The state and responsiveness of the renin-angiotensin-aldosterone system in patients with type II diabetes mellitus. Am J Hypertens 1999; 12:348-355.

32. Feman SS, Mericle RA, Reed GW, May JM, Workman RJ. Serum angiotensin converting enzyme in diabetic patients. Am J Med Sci 1993; 305:280-284.

33. Marre M, Bernadet P, Gallois Y, Savagner F, Guyene TT, Hallab M, Cambien F, a Passa P, Alhenc-Gelas F. Relationships between angiotensin I converting enzyme

Reducing Blood Pressure Naturally

Reducing Blood Pressure Naturally

Do You Suffer From High Blood Pressure? Do You Feel Like This Silent Killer Might Be Stalking You? Have you been diagnosed or pre-hypertension and hypertension? Then JOIN THE CROWD Nearly 1 in 3 adults in the United States suffer from High Blood Pressure and only 1 in 3 adults are actually aware that they have it.

Get My Free Ebook


Post a comment